Potential Anti-inflammatory Effects of Nanocurcumin via Modulation of MicroRNA-21 and MicroRNA 34a in Osteoarthritis Patients
Reports of Biochemistry and Molecular Biology · 2025
DOI: 10.66224/rbmb.14.2.282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reports of Biochemistry and Molecular Biology, 2025. Verfasst von Sepideh Palizban und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Osteoarthritis (OA) is the most common type of arthritis, characterized by inflammation that can affect the joint structures, leading to pain and disability, and is directly linked to ageing. As an epigenetic risk factor, microRNAs (miRNAs), small non-coding RNAs, can play a role in OA pathogenesis by regulating genes involved in processes such as inflammation, apoptosis, and autophagy. Due to the unique therapeutic potential of curcumin, isolated from Curcuma longa, particularly its anti-inflammatory properties, the current study aimed to investigate the effect of nanomicelle formulation of curcumin, named SinaCurcumin®, on the expression of miRNA-21 and miRNA-34a genes in OA patients.
Methods
Thirty female patients with osteoarthritis were randomly assigned to two equal groups, who received nanocurcumin (n=15) and placebo (n=15) in a double-blind clinical trial for 3 months. The gene expression levels of miRNA-21 and miRNA-34a were evaluated using the SYBR® Green Real-Time PCR method. The association between the changes in expression of miRNA-21 and miRNA-34a and the changes in clinical and laboratory indexes in OA patients was analyzed using Spearman's rank correlation.
Results
In the nanocurcumin group, the gene expression of miRNA-21 and miRNA-34a was significantly reduced, while no significant changes were observed in the placebo group. Also, there was a significant positive correlation between the downregulation of miRNA-21 and miRNA-34a and a decline in clinical and laboratory indexes (Visual Analog Scale and C-reactive protein) in patients receiving nanocurcumin.
Conclusion
Curcumin may provide a promising therapeutic perspective for improving inflammation in OA, through its modulatory effects on miRNA-21 and miRNA-34a.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
- Innovative Medical Research Center, Faculty of Medicine, Mashhad Medical Science, Islamic Azad University, Mashhad, Iran.
- Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Zitieren
APA
Palizban, S., Karimi, E., Dehnavi, S., Sabouni, N., Atabaki, M., & Mohammadi, M. (2025). Potential Anti-inflammatory Effects of Nanocurcumin via Modulation of MicroRNA-21 and MicroRNA 34a in Osteoarthritis Patients. Reports of Biochemistry and Molecular Biology. https://doi.org/10.66224/rbmb.14.2.282
Vancouver
Palizban S, Karimi E, Dehnavi S, Sabouni N, Atabaki M, Mohammadi M. Potential Anti-inflammatory Effects of Nanocurcumin via Modulation of MicroRNA-21 and MicroRNA 34a in Osteoarthritis Patients. Reports of Biochemistry and Molecular Biology. 2025. doi:10.66224/rbmb.14.2.282
BibTeX
@article{Palizban2025,
author = {Palizban, Sepideh and Karimi, Ehsan and Dehnavi, Sajad and Sabouni, Nasim and Atabaki, Mahdi and Mohammadi, Mojgan},
title = {Potential Anti-inflammatory Effects of Nanocurcumin via Modulation of MicroRNA-21 and MicroRNA 34a in Osteoarthritis Patients},
journal = {Reports of Biochemistry and Molecular Biology},
year = {2025},
doi = {10.66224/rbmb.14.2.282}
}
EUVIMED